Description The coronavirus outbreak will further increase this number dramatically as COVID-19 often leads to MOF.
 Periodic Reporting for period 1 - ADVOS-COVID-19 (Increasing Survival of Patients with Severe SARS-CoV-2 Infection and/or Multi Organ Failure by up to 30% with ADVOS - ADVanced Organ Support) Result title Periodic Reporting for period 1 - ADVOS-COVID-19 (Increasing Survival of Patients with Severe SARS-CoV-2 Infection and/or Multi Organ Failure by up to 30% with ADVOS - ADVanced Organ Support) Result description ADVITOS` innovation – the ADVOS therapy system - has the potential to increase the survival of COVID-19 patients suffering from severe multi organ failure (MOF). Result comments ADVOS-COVID-19 Result acronym ADVOS-COVID-19-748536

Description The aim of this project is to take TrachFlush to market and battle the COVID-19 outbreak.
 Periodic Reporting for period 1 - COVID-19 ICU-CARE (COVID-19 ICU-CARE – A ground-breaking ICU bed-side COVID-19 trachea flushing system that can cut healthcare costs and reduce COVID-19 spread between ICU patients and staff) Result title Periodic Reporting for period 1 - COVID-19 ICU-CARE (COVID-19 ICU-CARE – A ground-breaking ICU bed-side COVID-19 trachea flushing system that can cut healthcare costs and reduce COVID-19 spread between Result description Problem:When the severely ill COVID-19 patients are admitted to the Intensive Care Unit (ICU) for respiratory support (breathing with the support of a mechanical ventilator), it is crucial that the upper Result comments COVID-19 ICU-CARE Result acronym COVID-19 ICU-CARE-787997

Description The COVID-19 and a long list of potential clients contacting us for a solution made us prioritize the detection of COVID-19.
 Periodic Reporting for period 2 - NanoScent COVID-19 (Novel COVID-19 POC Screening Tool Based on Proprietary Nano-Sensors and ML Techniques) Result title Periodic Reporting for period 2 - NanoScent COVID-19 (Novel COVID-19 POC Screening Tool Based on Proprietary Nano-Sensors and ML Techniques) Result description To contain the COVID-19 pandemic, the WHO has published travel advice for international traffic. Result comments NanoScent COVID-19
 Continuous Report on Communication and Commercialization Activities Result comments NanoScent COVID-19 Result acronym NanoScent COVID-19-717075
 Project QA Handbook Result comments NanoScent COVID-19
 Pathophysiology of SARS-CoV-2 Infection in the Upper Respiratory Tract and Its Relation to Breath Volatile Organic Compounds Result comments NanoScent COVID-19
 CE mark for IVD Directive 98/79/EC Result comments NanoScent COVID-19
 Commercial mobile application Result comments NanoScent COVID-19
 Final Report on Communication and Commercialization Activities Result comments NanoScent COVID-19

Description COVID-19 telemedicine will provide the solution for remote monitoring and telemedicine for COVID-19 patients.
 Periodic Reporting for period 1 - Covid-19Telemedicine (COVID-19 Telemedicine – an infectious disease management tool for governments all over Europe that will reduce casualties from COVID-19 as well as prepare governments for the next wave of epidemics.) Result title Periodic Reporting for period 1 - Covid-19Telemedicine (COVID-19 Telemedicine – an infectious disease management tool for governments all over Europe that will reduce casualties from COVID-19 as well as Result description In early 2020, the novel coronavirus (COVID-19) spread worldwide with a high transmission rate. Result comments Covid-19Telemedicine
 Documentatinon for complience Result comments Covid-19Telemedicine Result acronym Covid-19Telemedicine-863380
 Translated training documents, checklists and videos Result comments Covid-19Telemedicine
 Training documents, Checklists and videos Result comments Covid-19Telemedicine
 Training plans Result comments Covid-19Telemedicine

Description health preparedness and response to COVID-19.
 Absence of association between 2019‐20 influenza vaccination and COVID‐19: Results of the European I‐MOVE‐COVID‐19 primary care project, March‐August 2020 Result title Absence of association between 2019‐20 influenza vaccination and COVID‐19: Results of the European I‐MOVE‐COVID‐19 primary care project, March‐August 2020 Result comments I-MOVE-COVID-19 Result acronym I-MOVE-COVID-19-722372
 Periodic Reporting for period 1 - I-MOVE-COVID-19 (Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic) Result description Objective of proposal: We aim to obtain epidemiological, clinical and virological information about COVID-19 and patients infected with COVID-19, through provision of a flexible surveillance platform Result comments I-MOVE-COVID-19
 WP2 Surveillance monitoring and evaluation protocol Result comments I-MOVE-COVID-19
 Surveillance monitoring and evaluation protocol Result comments I-MOVE-COVID-19
 Website Result comments I-MOVE-COVID-19
 Hypertension and Related Comorbidities as Potential Risk Factors for COVID-19 Hospitalization and Severity: A Prospective Population-Based Cohort Study Result comments I-MOVE-COVID-19
 Utility of a commercial RT-qPCR assay to detect SARS-CoV-2 gene variations as an indicator of lineages Result comments I-MOVE-COVID-19
 Protocols for priority studies later in the epidemic Result comments I-MOVE-COVID-19
 Study reports on priority studies early in the epidemic Result comments I-MOVE-COVID-19
 Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021 Result comments I-MOVE-COVID-19
 WP2 Second surveillance bulletin including data from all sentinel sites Result comments I-MOVE-COVID-19
 Influenza Vaccination and Risk of SARS-CoV-2 Infection in a Cohort of Health Workers Result comments I-MOVE-COVID-19
 WP2 First surveillance bulletin including data from all sentinel sites Result comments I-MOVE-COVID-19
 First surveillance bulletin including data from all sentinel sites Result comments I-MOVE-COVID-19
 Pooled database for clinical samples Result comments I-MOVE-COVID-19
 Self-Collection of Saliva Specimens as a Suitable Alternative to Nasopharyngeal Swabs for the Diagnosis of SARS-CoV-2 by RT-qPCR Result comments I-MOVE-COVID-19
 Altitude and SARS-CoV-2 Infection in the First Pandemic Wave in Spain Result comments I-MOVE-COVID-19
 Second surveillance bulletin including data from all sentinel sites Result comments I-MOVE-COVID-19
 Independent Role of Severe Obesity as a Risk Factor for COVID‐19 Hospitalization: A Spanish Population‐Based Cohort Study Result comments I-MOVE-COVID-19
 Hospital Phased surveillance protocol Result comments I-MOVE-COVID-19
 Product-specific COVID-19 vaccine effectiveness against secondary infection in close contacts, Navarre, Spain, April to August 2021 Result comments I-MOVE-COVID-19
 First Report Steering-Scientific Committee, scientific meeting Result comments I-MOVE-COVID-19
 Emergence of SARSCoV-2 variant B.1.575.2, containing the E484K mutation in the spike protein, in Pamplona, Spain, May to June 2021 Result comments I-MOVE-COVID-19
 Report to identify synergies and areas for collaboration Result comments I-MOVE-COVID-19
 Hypertension and Related Comorbidities as Potential Risk Factors for COVID-19 Hospitalization and Severity: A Prospective Population-Based Cohort Study Result comments I-MOVE-COVID-19
 Protocols for priority studies early in the epidemic Result comments I-MOVE-COVID-19
 Phased surveillance protocol Result comments I-MOVE-COVID-19
 Report describing existing information on COVID-19 and knowledge gaps and recommendations on short-term and longer-term priority studies. Result comments I-MOVE-COVID-19
 Report kick-off ST-SC Committee meeting Result comments I-MOVE-COVID-19
 Report describing current COVID-19 surveillance practices and recommendations Result comments I-MOVE-COVID-19
 Risk Factors of Infection, Hospitalization and Death from SARS-CoV-2: A Population-Based Cohort Study. Result comments I-MOVE-COVID-19
 Interim activity Report Result comments I-MOVE-COVID-19
 Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021 Result comments I-MOVE-COVID-19
 Report describing current COVID-19 hospital surveillance practices Result comments I-MOVE-COVID-19

Description CEPI’s COVID-19 vaccine programme development efforts.
 Periodic Reporting for period 1 - COVID-19 VACCINES (PROPOSAL FOR FUNDING RESEARCH DEVELOPMENT AND MANUFACTURING OF VACCINE AGAINST COVID-19) Result title Periodic Reporting for period 1 - COVID-19 VACCINES (PROPOSAL FOR FUNDING RESEARCH DEVELOPMENT AND MANUFACTURING OF VACCINE AGAINST COVID-19) Result description The COVID-19 outbreak has in a short timeframe grown... Result comments COVID-19 VACCINES Result acronym COVID-19 VACCINES-854125
 Calls texts and opening of the calls online Result comments COVID-19 VACCINES

Description More than 2.7 million hospitalisations of COVID-19-infected patients have occurred in Europe alone since the outbreak of the coronavirus in 2020.
 "Report on virtual meeting with the other successful projects working on COVID-19 therapeutics funded under the Horizon Europe call ""HORIZON-HLTH-2021-CORONA-01" Result title "Report on virtual meeting with the other successful projects working on COVID-19 therapeutics funded under the Horizon Europe call ""HORIZON-HLTH-2021-CORONA-01"
 Periodic Reporting for period 1 - COVend (Biomarker and AI-supported FX06 therapy to prevent progression from mild and moderate to severe stages of COVID-19) Result description COVID-19 has been distinguished as a vascular disease detrimentally affecting many biological pathways.

Description Since the beginning of the pandemic XENOTHERA has initiated a project to develop a new treatment against COVID-19 based on its technology.
 Evaluation of the safety and efficacy of XAV-19 in patients with COVID-19-induced moderate pneumonia: study protocol for a randomized, double-blinded, placebo-controlled phase 2 (2a and 2b) trial Result title Evaluation of the safety and efficacy of XAV-19 in patients with COVID-19-induced moderate pneumonia: study protocol for a randomized, double-blinded, placebo-controlled phase 2 (2a and 2b) trial
 Periodic Reporting for period 1 - BRIGHT (Treat severe cases of infection at COV with XAV-19) Result description The issue addressed in BRIGHT by XENOTHERA is the treatment of coronavirus disease 2019 (COVID-19). The goal is to reduce progression of mild to severe disease.

Description An AI platform to support medical practitioners to screen potential COVID-19 patients using medical imaging.
 Periodic Reporting for period 1 - CoronAI (AI software for the automated detection of covid-19 infection on chest CT) Result title Periodic Reporting for period 1 - CoronAI (AI software for the automated detection of covid-19 infection on chest CT) Result description Aidence is creating a new product to automatically analyse chest CT scans and diagnose the presence of corona (covid-19) viral infection.

Description The current outbreak of COVID-19 is incisively pointing towards the importance of optimal mechanical ventilation in Intensive Care. Improved mechanical ventilation saves lives.
 A case report of individualized ventilation in a COVID-19 patient – new possibilities and caveats to consider with flow-controlled ventilation Result title A case report of individualized ventilation in a COVID-19 patient – new possibilities and caveats to consider with flow-controlled ventilation
 Periodic Reporting for period 2 - Jane (Harmless Respiration for Intensive Care Patients decreasing mortality and shortening stays – including COVID-19 patients) Result description The outbreak of COVID-19 underlined the importance of optimal mechanical ventilation at the Intensive Care Unit (ICU). It confirmed that improving mechanical ventilation saves lives.

Description COVID-19 and thereby select which patients that could be discharged or admitted.
 Soluble Urokinase Receptor (SuPAR) in COVID-19–Related AKI Result title Soluble Urokinase Receptor (SuPAR) in COVID-19–Related AKI Result comments RISCinCOVID
 Periodic Reporting for period 2 - RISCinCOVID (Optimal use of hospital resources and intervention using suPAR for improving prognosis and care for patients with COVID-19) Result description The overall objective of RISCinCOVID was to ensure optimal use of hospital resources and intervention using suPAR for improving prognosis and care for patients with COVID-19. Result comments RISCinCOVID
 Dissimination of results Result comments RISCinCOVID Result acronym RISCinCOVID-721925
 Study approval Result comments RISCinCOVID
 Approval by ethical committee in countries where suPAR is not already routine Result comments RISCinCOVID
 Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial Result comments RISCinCOVID
 An open label trial of anakinra to prevent respiratory failure in COVID-19 Result comments RISCinCOVID
 Reporting of results Result comments RISCinCOVID
 First patient enrolled Result comments RISCinCOVID
 Registration and consent Result comments RISCinCOVID
 Final data reporting Result comments RISCinCOVID

Description COVID-19 is a global health problem and we need to be ready for this.
 Periodic Reporting for period 2 - RapCo-19 (Rapid COVID-19 Passive Therapy Response Platform) Result title Periodic Reporting for period 2 - RapCo-19 (Rapid COVID-19 Passive Therapy Response Platform) Result description COVID-19 continues to be a global health problem over a year after the initial outbreak. The original scope of the project was to provide a fully validated process to use... Result comments RapCo-19 Result acronym RapCo-19-669935
 Proven pre-clinical safety and efficacy of the SARS-CoV-2 vaccine and antibody drug product Result comments RapCo-19
 Highly purified antibody therapy for preclinical studies Result comments RapCo-19
 Deployment of SARS-Cov-2 antibody passive vaccine therapy Result comments RapCo-19
 Antibody DNA sequence of lead candidate(s) Result comments RapCo-19

Description to COVID-19, ensures inclusion of all expertise needed and translation of recommendations to different social and economic settings.
 Social Isolation Among Older Adults in the Time of COVID-19 Result title Social Isolation Among Older Adults in the Time of COVID-19
 Periodic Reporting for period 1 - ORCHESTRA (Connecting European Cohorts to Increase Common and Effective Response to SARS-CoV-2 Pandemic: ORCHESTRA) Result description -19 patients and to inform on longer-term consequences of COVID-19 on...

Description The mission of RESPOND is 1) to identify critical resilience factors and specific vulnerable groups at risk of immediate and long-term adverse mental health impact of the COVID-19 pandemic; 2) To improve
 Policy recommendations on short-term impact of COVID-19 pandemic Result title Policy recommendations on short-term impact of COVID-19 pandemic
 Periodic Reporting for period 2 - RESPOND (Improving the Preparedness of Health Systems to Reduce Mental Health and Psychosocial Concerns resulting from the COVID-19 Pandemic) Result description The COVID-19 pandemic has importantly affected mental health and wellbeing of European citizens during the past two years.

Description ESSENCE aims at transforming the lessons learnt from the COVID-19 in a huge opportunity that exploits technology toward a deep evolution of the services targeting vulnerable populations: non- or pre-frail
 Technology use characteristics among older adults during the COVID-19 pandemic: A cross-cultural survey Result title Technology use characteristics among older adults during the COVID-19 pandemic: A cross-cultural survey
 Periodic Reporting for period 1 - ESSENCE (ESSENCE: Empathic platform to personally monitor, Stimulate, enrich, and aSsist Elders aNd Children in their Environment) Result description ESSENCE aims at transforming the lessons learnt from the COVID-19 in a huge opportunity that exploits technology toward a deep evolution of the services targeting vulnerable populations: non- or pre-frail

Description unCoVer is a functional network of research institutions collecting data derived from the provision of care to COVID-19 patients by health systems across Europe and internationally.
 COVID-19 RWD processing Result title COVID-19 RWD processing
 Periodic Reporting for period 1 - unCoVer (Unravelling Data for Rapid Evidence-Based Response to COVID-19) Result description The outbreak of COVID-19, caused by SARS-CoV-2, was declared a public health emergency of international concern by the WHO on 30 January 2020 and a pandemic on 11 March 2020.

Description The novel corona virus causing COVID-19 overwhelmed Europe and the world in just a few weeks’ time.
 European pipeline of COVID-19 solutions Result title European pipeline of COVID-19 solutions Result comments INNO4COV-19
 Periodic Reporting for period 1 - INNO4COV-19 (Boosting Innovation for COVID-19 Diagnostic, Prevention and Surveillance.) Result description The novel corona virus causing COVID-19 overwhelmed Europe and the world in just a few weeks’ time. Result comments INNO4COV-19
 Specification Sheets - Templates and Guidelines (SP1) Result comments INNO4COV-19 Result acronym INNO4COV-19-790922
 Specifications Sheets-Templates and guidelines (SP4) Result comments INNO4COV-19
 Website development Result comments INNO4COV-19
 Catalogues of the Service/Product portfolio (SP2) Result comments INNO4COV-19
 Catalogues of the Service/Product portfolio (SP1) Result comments INNO4COV-19
 Catalogues of the Service/Product portfolio (SP3) Result comments INNO4COV-19
 Specification Sheets-Templates and guidelines (SP3) Result comments INNO4COV-19
 Specification Sheets - Templates and guidelines (SP2) Result comments INNO4COV-19
 Catalogues of the Service / Product portfolio (SP4) Result comments INNO4COV-19
 Sterilisation seminar Result comments INNO4COV-19
 Polymeric substrate properties tailored by irradiation Result comments INNO4COV-19
 "Report on Dissemination activities #1" Result comments INNO4COV-19
 56-3: New Ultra Low-Power High Brightness Microdisplays Enabling Broad Applications Result comments INNO4COV-19
 Report on Training activities Result comments INNO4COV-19
 Online repository of business support and open innovation resources Result comments INNO4COV-19

Description -19 disease.
 Knowledge Graphs for COVID-19: An Exploratory Review of the Current Landscape Result title Knowledge Graphs for COVID-19: An Exploratory Review of the Current Landscape Result comments icovid
 Periodic Reporting for period 1 - icovid (AI-based chest CT analysis enabling rapid COVID diagnosis and prognosis) Result description The impact COVID-19 has on health care systems and society as a whole is enormous. Result comments icovid
 Comparative study of deep learning methods for the automatic segmentation of lung, lesion and lesion type in CT scans of COVID-19 patients Result comments icovid Result acronym icovid-748201
 New release of the icolung software v1 Result comments icovid
 Limitations of Only Reporting the Odds Ratio in the Age of Precision Medicine: A Deterministic Simulation Study Result comments icovid
 Can predicting COVID-19 mortality in a European cohort using only demographic and comorbidity data surpass age-based prediction: An externally validated study Result comments icovid
 Covid19Risk.ai: An Open Source Repository and Online Calculator of Prediction Models for Early Diagnosis and Prognosis of Covid-19 Result comments icovid
 Explainable-by-design Semi-Supervised Representation Learning for COVID-19 Diagnosis from CT Imaging Result comments icovid

Description ATAC aims at developing passive immunotherapy against COVID-19.
 Antibody therapy for COVID-19 Result title Antibody therapy for COVID-19
 Periodic Reporting for period 2 - ATAC (Antibody therapy against coronavirus (COVID-19)) Result description The emergence and spread of the novel human severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiological agent of the coronavirus disease 2019 (COVID-19), has led to a pandemic with major

Description ACE2 is also the key receptor for SARS-CoV-2 Spike protein and has got centre stage for novel therapies and a fundamental understanding of COVID-19.
 Human recombinant soluble ACE2 in severe COVID-19 Result title Human recombinant soluble ACE2 in severe COVID-19
 Periodic Reporting for period 2 - MAD-CoV 2 (Modern approaches for developing antivirals against SARS-CoV 2) Result description The MAD-CoV 2 project is a collaboration of world-leading researchers and innovative industry partners that aims to develop and deliver treatment for COVID-19 patients, significantly increasing the capacity

Description The COVID-19 outbreak causes world health care systems to crumble under the load.
 Periodic Reporting for period 1 - PyXy.AI (Telehealth-ready AI-powered multi-parametric system for surveillance of COVID-19 and cardio-pulmonary chronic patients) Result title Periodic Reporting for period 1 - PyXy.AI (Telehealth-ready AI-powered multi-parametric system for surveillance of COVID-19 and cardio-pulmonary chronic patients) Result description with COVID-19 and acute complications of their chronic condition due...

Description Being able to identify COVID-19 patients at risk of developing cardiovascular events leading to death would allow improving surveillance and care.
 Evidence for Biological Age Acceleration and Telomere Shortening in COVID-19 Survivors. Result title Evidence for Biological Age Acceleration and Telomere Shortening in COVID-19 Survivors.
 Periodic Reporting for period 1 - COVIRNA (A diagnostic test to improve surveillance and care of COVID-19 patients) Result description The COVID-19 pandemic is still at a rapidly evolving phase. COVID-19 is caused by SARS-COV2 infection and affects individuals with varied severity.

Description -19 patients, while reducing the burden on clinical staff and healthcare costs.
 ENVISION – Improve intensive care of COVID-19 patients with artificial intelligence Result title ENVISION – Improve intensive care of COVID-19 patients with artificial intelligence
 Periodic Reporting for period 1 - ENVISION (Intelligent plug-and-play digital tool for real-time surveillance of COVID-19 patients and smart decision-making in Intensive Care Units) Result description COVID-19 patient data from the ICU – the Sandman.IC.

Description Policymakers and public health experts unanimously recognise the disproportionate impacts of COVID-19 on vulnerable persons: even in countries with well-developed responses, the outbreak and its repercussions
 Viruses of the mind. Coping and joking about COVID-19. Bi-monthly report 7, January 2022. Result title Coping and joking about COVID-19. Bi-monthly report 7, January 2022.
 Periodic Reporting for period 1 - COVINFORM (COronavirus Vulnerabilities and INFOrmation dynamics Research and Modelling) Result description Policymakers and public health experts unanimously recognise the disproportionate impacts of COVID-19 on so-called vulnerable groups: even in countries with well-developed responses, the outbreak and its

Description The impact of the COVID-19 pandemic has been deep and wide.
 Monitoring COVID‐19 contagion growth Result title Monitoring COVID‐19 contagion growth
 Periodic Reporting for period 2 - PERISCOPE (Pan-European Response to the ImpactS of COVID-19 and future Pandemics and Epidemics) Result description Significant knowledge gaps on the effects of the COVID-19 pandemic persist, especially in terms of the socio-economic and behavioural impacts of the pandemic, and the costs and benefits of alternative

Description According to the World Health Organisation Situation Report of March 28th 2020, 571,659 patients were diagnosed with Coronavirus Disease 2019 (COVID-19) and 26,493 deaths were reported globally.
 Rethinking informed consent in the time of COVID-19: An exploratory survey Result title Rethinking informed consent in the time of COVID-19: An exploratory survey
 Design, immunogenicity, and efficacy of a pan-sarbecovirus dendritic-cell targeting vaccine Result description Wang, Jerome Ellis, Amandine Sansoni, Camille Pierini, Quentin Bardin, Manon Fabregue, Sarah Sharkaoui, Philippe Hoest, Léa Dupaty, Florence Picard, Marwa El Hajj, Mireille Centlivre, Jade Ghosn, French COVID

Description To evaluate algorithm performance, the cohort will be tested for COVID-19 antibodies at the end of follow-up.
 Periodic Reporting for period 1 - COVID-RED (COVID-19 infections - Remote Early Detection) Result title Periodic Reporting for period 1 - COVID-RED (COVID-19 infections - Remote Early Detection) Result description The World Health Organization (WHO) declared the COVID-19 pandemic a Public Health Emergency of International Concern. Result comments COVID-RED
 The performance of wearable sensors in the detection of SARS-CoV-2 infection: a systematic review Result comments COVID-RED Result acronym COVID-RED-836394
 Data management plan (3rd iteration) Result comments COVID-RED
 Detailed project plans plus tracking tools, to be maintained throughout the life of the project Result comments COVID-RED
 Tendering procedure description Result comments COVID-RED
 Definition of the areas of collaboration Result comments COVID-RED
 Data management plan (2nd iteration) Result comments COVID-RED
 Report on small feasibility study & proposed adaptations to the protocol to be made Result comments COVID-RED
 A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial Result comments COVID-RED
 Contact database of stakeholders and key project contacts Result comments COVID-RED
 Second report from the advisory board Result comments COVID-RED
 First report from the advisory board Result comments COVID-RED
 Report describing internal and external communication outputs Result comments COVID-RED
 Full data management plan (1st iteration) Result comments COVID-RED
 First biannual report on COVID-RED progress, including ethics report and impact assessment Result comments COVID-RED
 Initial CRF development completed Result comments COVID-RED
 Project website, templates, and social media tools Result comments COVID-RED
 Report describing an initial dissemination, communication and exploitation plan Result comments COVID-RED
 Project management plans Result comments COVID-RED
 Report on the interventions costs/price of the Ava monitoring device Result comments COVID-RED
 Interim report on testing results for SARS-CoV-2 virus Result comments COVID-RED
 Study protocol Result comments COVID-RED
 Midterm recruitment report Result comments COVID-RED
 Testing protocols Result comments COVID-RED
 Updated data capture and transmission strategies Result comments COVID-RED
 Study subject approvals package Result comments COVID-RED
 Report on sustainability model for data storage Result comments COVID-RED
 Report with stakeholder landscape analysis Result comments COVID-RED
 Report on relevant regulatory requirements Result comments COVID-RED
 Report on final analysis of results Result comments COVID-RED
 Data management plan (final version) Result comments COVID-RED
 Report describing a final dissemination, communication and exploitation plan Result comments COVID-RED
 Report on the outcomes and associated hospital costs Result comments COVID-RED
 A first draft of a scientific paper reporting on the results of the cost-consequence analysis for publication in an international peer-review journal Result comments COVID-RED
 Report on lessons learned to inform checklist creation Result comments COVID-RED
 Report on the barriers and enablers of remote monitoring devices and apps for detecting early signs of COVID-19 infection Result comments COVID-RED
 Third report from the advisory board Result comments COVID-RED
 Regulatory management plan Result comments COVID-RED
 Report describing sustainability plan Result comments COVID-RED
 Final report on testing results for SARS-CoV-2 virus and SARS-CoV-2 antibodies Result comments COVID-RED
 Investigation of the use of a sensor bracelet for the presymptomatic detection of changes in physiological parameters related to COVID-19: an interim analysis of a prospective cohort study (COVI-GAPP) Result comments COVID-RED

Description The non-intended consequences of the epidemic control decisions to contain the COVID-19 pandemic are huge and affect the well-being of European citizens in terms of economics, social relationships and
 Predicting COVID-19 Vaccine Uptake Result title Predicting COVID-19 Vaccine Uptake
 Periodic Reporting for period 2 - SHARE-COVID19 (Non-intended health, economic and social effects of the COVID-19 epidemic control decisions: Lessons from SHARE (SHARE-COVID19)) Result description The non-intended consequences of the epidemic control decisions to contain the COVID-19 pandemic are huge and affect the well-being of European citizens in terms of economics, social relationships and

Description The accumulation of fluid in the lungs is a significant feature of the pathology in patients with severe Covid-19 infection.
 The INVENT COVID trial: a structured protocol for a randomized controlled trial investigating the efficacy and safety of intravenous imatinib mesylate (Impentri®) in subjects with acute respiratory distress syndrome induced by COVID-19 Result title syndrome induced by COVID-19
 Periodic Reporting for period 1 - Impentri (Development of Impentri, an intravenous imatinib formulation for Covid-19 acute respiratory distress syndrome (ARDS).) Result description The Impentri IMI2 consortium was awarded a €3.6M grant, to re-purpose an existing licensed oncology drug, imatinib for the treatment of Acute Respiratory Distress Syndrome (ARDS) induced by COVID-19.

Description -19 patients, including VOC carriers.
 Periodic Reporting for period 1 - EPIC-CROWN-2 (Equine Polyclonal antibodies Immunotherapy against COVID-19/SARS-CoV2–VOC) Result title Periodic Reporting for period 1 - EPIC-CROWN-2 (Equine Polyclonal antibodies Immunotherapy against COVID-19/SARS-CoV2–VOC)